Revolution Medicines, Inc. (RVMD)
Biological Products, (No Diagnostic Substances)
Latest Price
$205.11
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
12.74
P/B Ratio
16.10
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 13.70M | $2.56B | 6.39% | +2.48M | 2026-06-30 |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 13.55M | $2.54B | 6.32% | -- | 2026-06-30 |
| FMR LLC | 12.20M | $2.28B | 5.69% | +3.74M | 2026-06-30 |
| BAKER BROS. ADVISORS LP | 11.44M | $2.14B | 5.34% | +1.89M | 2026-06-30 |
| Jupiter Topco LLC | 10.74M | $2.01B | 5.01% | -- | 2026-06-30 |
| Darwin Global Management, Ltd. | 10.63M | $2.05B | 4.96% | +8.42M | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 9.09M | $1.70B | 4.24% | +726.4K | 2026-06-30 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 8.29M | $1.55B | 3.87% | +792.2K | 2026-06-30 |
| Nextech Invest Ltd. | 7.60M | $1.42B | 3.55% | -- | 2026-06-30 |
| Paradigm Biocapital Advisors LP | 6.36M | $1.19B | 2.97% | -294.4K | 2026-06-30 |